BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33229139)

  • 1. Diffuse large B-cell lymphoma: Time to focus on circulating blood nucleic acids?
    Regazzo G; Marchesi F; Spagnuolo M; Díaz Méndez AB; Masi S; Mengarelli A; Rizzo MG
    Blood Rev; 2021 May; 47():100776. PubMed ID: 33229139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor DNA: clinical roles in diffuse large B cell lymphoma.
    Wu FT; Lu L; Xu W; Li JY
    Ann Hematol; 2019 Feb; 98(2):255-269. PubMed ID: 30368587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review.
    Arzuaga-Mendez J; Prieto-Fernández E; Lopez-Lopez E; Martin-Guerrero I; García-Ruiz JC; García-Orad A
    Crit Rev Oncol Hematol; 2019 Jul; 139():7-15. PubMed ID: 31112884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
    Cherng HJ; Herrera A
    Curr Treat Options Oncol; 2024 May; 25(5):659-678. PubMed ID: 38656685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
    Sun R; Zheng Z; Wang L; Cheng S; Shi Q; Qu B; Fu D; Leboeuf C; Zhao Y; Ye J; Janin A; Zhao WL
    Mol Oncol; 2021 Jan; 15(1):246-261. PubMed ID: 33107145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
    Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
    Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
    Bohers E; Viailly PJ; Becker S; Marchand V; Ruminy P; Maingonnat C; Bertrand P; Etancelin P; Picquenot JM; Camus V; Menard AL; Lemasle E; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Lanic H; Libraire J; Vaudaux S; Pepin LF; Vera P; Tilly H; Jardin F
    Blood Cancer J; 2018 Aug; 8(8):74. PubMed ID: 30069017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.
    Pezzuto F; Buonaguro L; Buonaguro FM; Tornesello ML
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29597259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study.
    Rivas-Delgado A; Nadeu F; Enjuanes A; Casanueva-Eliceiry S; Mozas P; Magnano L; Castrejón de Anta N; Rovira J; Dlouhy I; Martín S; Osuna M; Rodríguez S; Simó M; Pinyol M; Baumann T; Beà S; Balagué O; Delgado J; Villamor N; Setoain X; Campo E; Giné E; López-Guillermo A
    Clin Cancer Res; 2021 Jan; 27(2):513-521. PubMed ID: 33122345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma.
    Hu R; Winter A; Hill BT
    Curr Oncol Rep; 2019 Apr; 21(5):44. PubMed ID: 30941515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
    Beheshti A; Stevenson K; Vanderburg C; Ravi D; McDonald JT; Christie AL; Shigemori K; Jester H; Weinstock DM; Evens AM
    Sci Rep; 2019 Nov; 9(1):17161. PubMed ID: 31748664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy in diffuse large B-cell lymphoma: utility in cell origin determination and survival prediction in Chinese patients.
    Li M; Ding N; Mi L; Shi Y; Du X; Yi Y; Yang L; Liu W; Zhu J
    Leuk Lymphoma; 2022 Mar; 63(3):608-617. PubMed ID: 34751093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating MicroRNAs as Potential Biomarkers for Lung Cancer.
    Müller S; Janke F; Dietz S; Sültmann H
    Recent Results Cancer Res; 2020; 215():299-318. PubMed ID: 31605236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL.
    Tabari E; Lovejoy AF; Lin H; Bolen CR; Lor Saelee S; Lefkowitz JP; Kurtz DM; Bottos A; Nielsen TG; Parreira JM; Luong KT
    Leuk Lymphoma; 2024 May; 65(5):618-628. PubMed ID: 38337191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs.
    Paszkiewicz-Kozik E; Paziewska A; Kulecka M; Dąbrowska M; Kluska A; Bałabas A; Piątkowska M; Ambrożkiewicz F; Tajer J; Osiadacz W; Romejko-Jarosińska J; Kotarska M; Żeber-Lubecka N; Karczmarski J; Popławska L; Mikula M; Rutkowski P; Walewski J; Ostrowski J
    Biomed Res Int; 2021; 2021():3212878. PubMed ID: 33628777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.
    Camus V; Jardin F; Tilly H
    Expert Rev Mol Diagn; 2017 Jun; 17(6):557-566. PubMed ID: 28415895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.
    Scherer F; Kurtz DM; Newman AM; Stehr H; Craig AF; Esfahani MS; Lovejoy AF; Chabon JJ; Klass DM; Liu CL; Zhou L; Glover C; Visser BC; Poultsides GA; Advani RH; Maeda LS; Gupta NK; Levy R; Ohgami RS; Kunder CA; Diehn M; Alizadeh AA
    Sci Transl Med; 2016 Nov; 8(364):364ra155. PubMed ID: 27831904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
    Lawrie CH; Gal S; Dunlop HM; Pushkaran B; Liggins AP; Pulford K; Banham AH; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS; Harris AL
    Br J Haematol; 2008 May; 141(5):672-5. PubMed ID: 18318758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
    Nesic M; Bødker JS; Terp SK; Dybkær K
    Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.